{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:07:09Z","timestamp":1775279229370,"version":"3.50.1"},"reference-count":43,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.5551\/jat.65852","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T22:08:43Z","timestamp":1766786923000},"page":"503-519","source":"Crossref","is-referenced-by-count":0,"title":["Higher Small Dense LDL Cholesterol to LDL Cholesterol Ratio is Associated with Glomerular Hyperfiltration in Adults without Diabetes"],"prefix":"10.5551","volume":"33","author":[{"given":"Nobuhisa","family":"Morimoto","sequence":"first","affiliation":[{"name":"Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"},{"name":"Medical Informatics, Institute of Science Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Kansai Occupational Health Association, Acty Health Evaluation Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Toragai","sequence":"additional","affiliation":[{"name":"Kansai Occupational Health Association, Acty Health Evaluation Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kuroshima","sequence":"additional","affiliation":[{"name":"Kansai Occupational Health Association, Acty Health Evaluation Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Kansai Occupational Health Association, Senri LC Health Evaluation Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Ito","sequence":"additional","affiliation":[{"name":"Clinical Diagnostics Development Department, Denka Company Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Ai","sequence":"additional","affiliation":[{"name":"Medical Informatics, Institute of Science Tokyo Hospital"},{"name":"Department of Insured Medical Care Management, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, Adebayo OM, Afarideh M, Agarwal SK, Agudelo-Botero M, Ahmadian E, Al-Aly Z, Alipour V, Almasi-Hashiani A, Al-Raddadi RM, Alvis-Guzman N, Amini S, Andrei T, Andrei CL, Andualem Z, Anjomshoa M, Arabloo J, Ashagre AF, Asmelash D, Ataro Z, Atout MMW, Ayanore MA, Badawi A, Bakhtiari A, Ballew SH, Balouchi A, Banach M, Barquera S, Basu S, Bayih MT, Bedi N, Bello AK, Bensenor IM, Bijani A, Boloor A, Borz\u00ec AM, C\u00e1mera LA, Carrero JJ, Carvalho F, Castro F, Catal\u00e1-L\u00f3pez F, Chang AR, Chin KL, Chung SC, Cirillo M, Cousin E, Dandona L, Dandona R, Daryani A, Das Gupta R, Demeke FM, Demoz GT, Desta DM, Do HP, Duncan BB, Eftekhari A, Esteghamati A, Fatima SS, Fernandes JC, Fernandes E, Fischer F, Freitas M, Gad MM, Gebremeskel GG, Gebresillassie BM, Geta B, Ghafourifard M, Ghajar A, Ghith N, Gill PS, Ginawi IA, Gupta R, Hafezi-Nejad N, Haj-Mirzaian A, Haj-Mirzaian A, Hariyani N, Hasan M, Hasankhani M, Hasanzadeh A, Hassen HY, Hay SI, Heidari B, Herteliu C, Hoang CL, Hosseini M, Hostiuc M, Irvani SSN, Islam SMS, Jafari Balalami N, James SL, Jassal SK, Jha V, Jonas JB, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2020; 395: 709-733","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chu M, Wang AYM, Chan IHS, Chui SH, Lam CWK. Serum small-dense LDL abnormalities in chronic renal disease patients. Br J Biomed Sci, 2012; 69: 99-102","DOI":"10.1080\/09674845.2012.12069133"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nakano T, Tanaka S, Tsuruya K, Kitazono T. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study. Clin Exp Nephrol, 2021; 25: 385-393","DOI":"10.1007\/s10157-020-02000-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lanktree MB, Th\u00e9riault S, Walsh M, Par\u00e9 G. HDL cholesterol, LDL cholesterol, and triglycerides as risk factors for CKD: A Mendelian randomization study. Am J Kidney Dis, 2018; 71: 166-172","DOI":"10.1053\/j.ajkd.2017.06.011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shen H, Xu Y, Lu J, Ma C, Zhou Y, Li Q, Chen X, Zhu A, Shen G. Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients. BMC Nephrol, 2016; 17: 143","DOI":"10.1186\/s12882-016-0358-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ. Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol, 2015; 26: 1426-1433","DOI":"10.1681\/ASN.2014010115"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Dupuis ME, Nadeau-Fredette AC, Madore F, Agharazii M, Goupil R. Association of glomerular hyperfiltration and cardiovascular risk in middle-aged healthy individuals. JAMA Netw Open, 2020; 3: e202377","DOI":"10.1001\/jamanetworkopen.2020.2377"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant, 2012; 27: 1821-1825","DOI":"10.1093\/ndt\/gfr651"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, Bochud M. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis, 2010; 56: 303-312","DOI":"10.1053\/j.ajkd.2010.03.017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol, 2014; 34: 1069-1077","DOI":"10.1161\/ATVBAHA.114.303284"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. J Am Coll Cardiol, 2020; 75: 2122-2135","DOI":"10.1016\/j.jacc.2020.02.059"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nakamura M, Yamamoto Y, Imaoka W, Kuroshima T, Toragai R, Ito Y, Yoshida H, Ai M. Reference interval for serum concentration of small dense low-density lipoprotein cholesterol in the healthy Japanese population. Ann Clin Biochem, 2022; 59: 242-252","DOI":"10.1177\/00045632211066334"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Cachat F, Combescure C, Cauderay M, Girardin E, Chehade H. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clin J Am Soc Nephrol, 2015; 10: 382-389","DOI":"10.2215\/CJN.03080314"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kruschke JK. Bayesian analysis reporting guidelines. Nat Hum Behav, 2021; 5: 1282-1291","DOI":"10.1038\/s41562-021-01177-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kruschke JK. Doing Bayesian Data Analysis: A Tutorial with R, JAGS, and Stan, Second Ed. Academic Press; 2014","DOI":"10.1016\/B978-0-12-405888-0.00008-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sj\u00f6lander A, Vansteelandt S. Frequentist versus Bayesian approaches to multiple testing. Eur J Epidemiol, 2019; 34: 809-821","DOI":"10.1007\/s10654-019-00517-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Maeda I, Hayashi T, Sato KK, Koh H, Harita N, Nakamura Y, Endo G, Kambe H, Fukuda K. Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol, 2011; 6: 2462-2469","DOI":"10.2215\/CJN.00700111"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Makowski D, Ben-Shachar M, L\u00fcdecke D. bayestestR: describing effects and their uncertainty, existence and significance within the Bayesian framework. J Open Source Softw, 2019; 4: 1541","DOI":"10.21105\/joss.01541"},{"key":"20","unstructured":"20) Goodrich B, Gabry J, Ali I, Brilleman S. rstanarm: Bayesian applied regression modeling via Stan (R package version 2.32.1). 2024. Accessed July 31, 2024. https: \/\/mc-stan.org\/rstanarm\/"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Vehtari A, Gelman A, Simpson D, Carpenter B, B\u00fcrkner PC. Rank-normalization, folding, and localization: an improved R\u02c6 for assessing convergence of MCMC (with discussion). Bayesian Analysis, 2021; 16: 667-718","DOI":"10.1214\/20-BA1221"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kruschke JK. Rejecting or accepting parameter values in Bayesian estimation. Advances in Methods and Practices in Psychological Science, 2018; 1: 270-280","DOI":"10.1177\/2515245918771304"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Makowski D, Ben-Shachar MS, Chen SHA, L\u00fcdecke D. Indices of effect existence and significance in the Bayesian framework. Front Psychol, 2019; 10: 2767","DOI":"10.3389\/fpsyg.2019.02767"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nakamura Y, Okuda N, Turin TC, Fujiyoshi A, Okamura T, Hayakawa T, Yoshita K, Miura K, Ueshima H, NIPPON DATA80\/90 Research Group. Fatty acids intakes and serum lipid profiles: NIPPON DATA90 and the national nutrition monitoring. J Epidemiol, 2010; 20(Suppl 3): S544-S548","DOI":"10.2188\/jea.JE20090223"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kelly RK, Harris K, Muntner P, Woodward M. Variations in sex differences in major cardiometabolic risk factors by age and menopause status: results from the UK Biobank. Open Heart, 2025; 12: e003182","DOI":"10.1136\/openhrt-2025-003182"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hirano T, Satoh N, Kodera R, Hirashima T, Suzuki N, Aoki E, Oshima T, Hosoya M, Fujita M, Hayashi T, Ito Y. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort. J Diabetes Investig, 2022; 13: 657-667","DOI":"10.1111\/jdi.13697"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Lee SM, Park JY, Park MS, Park JH, Park M, Yoon HJ. Association of renal hyperfiltration with incident proteinuria - A nationwide registry study. PLoS One, 2018; 13: e0195784","DOI":"10.1371\/journal.pone.0195784"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Palatini P, Dorigatti F, Saladini F, Benetti E, Mos L, Mazzer A, Zanata G, Garavelli G, Casiglia E. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Am J Hypertens, 2012; 25: 1011-1016","DOI":"10.1038\/ajh.2012.73"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nankivell BJ, Nankivell LFJ, Elder GJ, Gruenewald SM. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy. EClinicalMedicine, 2020; 29-30: 100662","DOI":"10.1016\/j.eclinm.2020.100662"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Moriconi D, Sacchetta L, Chiriac\u00f2 M, Nesti L, Forotti G, Natali A, Solini A, Tric\u00f2 D. Glomerular hyperfiltration predicts kidney function decline and mortality in type 1 and type 2 diabetes: a 21-year longitudinal study. Diabetes Care, 2023; 46: 845-853","DOI":"10.2337\/dc22-2003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Thongtang N, Diffenderfer MR, Ooi EMM, Barrett PHR, Turner SM, Le NA, Brown WV, Schaefer EJ. Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin. J Lipid Res, 2017; 58: 1315-1324","DOI":"10.1194\/jlr.M073882"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ackermann K, Bonaterra GA, Kinscherf R, Schwarz A. Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages. Atherosclerosis, 2019; 281: 128-136","DOI":"10.1016\/j.atherosclerosis.2018.12.009"},{"key":"33","unstructured":"33) Jin Q, Luk AO, Lau ES, Tam CHT, Ozaki R, Lim CKP, Wu H, Jiang G, Chow EYK, Ng JK, Kong APS, Fan B, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JY, Tsang MW, Kam G, Lau IT, Li JK, Yeung VT, Lau E, Lo S, Fung S, Cheng YL, Chow CC, Huang Y, Lan HY, Szeto CC, So WY, Chan JCN, Ma RCW, Hong Kong Diabetes Biobank Study Group. Nonalbuminuric diabetic kidney disease and risk of all-cause mortality and cardiovascular and kidney outcomes in type 2 diabetes: findings from the Hong Kong Diabetes Biobank. Am J Kidney Dis, 2022; 80: 196-206.e1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol, 2012; 8: 293-300","DOI":"10.1038\/nrneph.2012.19"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Gutwein P, Abdel-Bakky MS, Doberstein K, Schramme A, Beckmann J, Schaefer L, Amann K, Doller A, K\u00e4mpfer-Kolb N, Abdel-Aziz AAH, El Sayed ESM, Pfeilschifter J. CXCL16 and oxLDL are induced in the onset of diabetic nephropathy. J Cell Mol Med, 2009; 13: 3809-3825","DOI":"10.1111\/j.1582-4934.2009.00761.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yamamoto T, Takabatake Y, Takahashi A, Kimura T, Namba T, Matsuda J, Minami S, Kaimori JY, Matsui I, Matsusaka T, Niimura F, Yanagita M, Isaka Y. High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. J Am Soc Nephrol, 2017; 28: 1534-1551","DOI":"10.1681\/ASN.2016070731"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kikuchi H, Chou CL, Yang CR, Chen L, Jung HJ, Park E, Limbutara K, Carter B, Yang ZH, Kun JF, Remaley AT, Knepper MA. Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics. Nat Commun, 2023; 14: 3481","DOI":"10.1038\/s41467-023-38958-9"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kanbay M, Copur S, Guldan M, Ozbek L, Hatipoglu A, Covic A, Mallamaci F, Zoccali C. Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states. Clin Kidney J, 2024; 17: sfae195","DOI":"10.1093\/ckj\/sfae195"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Park H, Kang MK, Song TJ. Association of renal hyperfiltration with incidence of dyslipidemia: a nationwide retrospective longitudinal cohort study. PLoS One, 2025; 20: e0324710","DOI":"10.1371\/journal.pone.0324710"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Chapman MJ, Orsoni A, Tan R, Mellett NA, Nguyen A, Robillard P, Giral P, Th\u00e9rond P, Meikle PJ. LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL. J Lipid Res, 2020; 61: 911-932","DOI":"10.1194\/jlr.P119000543"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M, Alberta Kidney Disease Network. Cause of death in patients with reduced kidney function. J Am Soc Nephrol, 2015; 26: 2504-2511","DOI":"10.1681\/ASN.2014070714"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Molitch ME, Gao X, Bebu I, de Boer IH, Lachin J, Paterson A, Perkins B, Saenger AK, Steffes M, Zinman B, Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group. Early glomerular hyperfiltration and long-term kidney outcomes in type 1 diabetes: the DCCT\/EDIC experience. Clin J Am Soc Nephrol, 2019; 14: 854-861","DOI":"10.2215\/CJN.14831218"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Gelman A, Hill J, Yajima M. Why we (usually) don\u2019t have to worry about multiple comparisons. J Res Educ Eff, 2012; 5: 189-211","DOI":"10.1080\/19345747.2011.618213"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65852\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:25:17Z","timestamp":1775276717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65852\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65852","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"65852"}}